Skip to main content
SpringerLink
Log in

Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database

World Journal of Urology volume 41, pages 529–536 (2023)Cite this article

Abstract

Introduction

GreenLight photoselective vaporization of the prostate (PVP) has gained widespread adoption as an option to traditional transurethral resection of the prostate. Prior reports expressed concern with the use of PVP in large prostates. The aim of this study was to investigate the adjusted outcomes of GreenLight PVP in men with large (≥ 80 cc) vs. small prostates (< 80 cc).

Methods

Data were obtained from the Global Greenlight Group which pools data from 7 high volume centers. Men with established benign prostatic hyperplasia who underwent GreenLight PVP using the XPS-180 W system between 2011 and 2019 were eligible and assigned into two groups based on their prostate size (≥ 80 and < 80 cc). 11 functional and perioperative covariates were collected. Analyses were adjusted for patient age and presence of median lobe.

Results

3426 men met the inclusion criteria. 34.6% (n = 1187) of patients had a large prostate size. Baseline age and prostate volume were significantly different between the groups. The magnitude of absolute improvement in unadjusted international prostate symptom score was significantly greater in the large (≥ 80 cc) prostate group at 12 months, with an absolute change of 19.17 points (95% CI 18.46–19.88; p < 0.01). There was also a significant drop in PVR at both 6- (p = 0.007) and 12 months (p = 0.005). There were no significant differences in transfusion (p = 0.42), hematuria (p = 0.80), or 30-day readmission rates (p = 0.28).

Conclusions

Greenlight PVP is a safe and effective alternative for patients with prostate sizes ≥ 80 cc, with durable outcomes relatively independent from prostate size.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—the GOLIATH study. Eur Urol 65(5):931–942. https://doi.org/10.1016/j.eururo.2013.10.040

    Article  PubMed  Google Scholar 

  2. Hueber PA, Bienz MN, Valdivieso R et al (2015) Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 194(2):462–469. https://doi.org/10.1016/j.juro.2015.03.113

    Article  PubMed  Google Scholar 

  3. Lerner LB, McVary KT, Barry MJ et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II—surgical evaluation and treatment. J Urol 206(4):818–826

    Article  PubMed  Google Scholar 

  4. Elshal AM, Soltan M, El-Tabey NA, Laymon M, Nabeeh A (2020) Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU Int 126(6):731–738. https://doi.org/10.1111/bju.15161

    Article  CAS  PubMed  Google Scholar 

  5. McConnell JD, Roehrborn CG, Bautista OM et al (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. 25. http://www.nejm.org

  6. Campobasso D, Marchioni M, Altieri V et al (2020) GreenLight photoselective vaporization of the prostate: one laser for different prostate sizes. J Endourol 34(1):54–62. https://doi.org/10.1089/end.2019.0478

    Article  PubMed  Google Scholar 

  7. Stone BV, Chughtai B, Kaplan SA, Te AE, Lee RK (2015) GreenLight laser for prostates over 100 ml: what is the evidence? Curr Opin Urol 26(1):28–34. https://doi.org/10.1097/MOU.0000000000000237

    Article  Google Scholar 

  8. Meskawi M, Hueber PA, Valdivieso R et al (2017) Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with large prostates (prostate volume > 100 cc). World J Urol 35(10):1603–1609. https://doi.org/10.1007/s00345-017-2007-7

    Article  PubMed  Google Scholar 

  9. Law KW, Tholomier C, Nguyen DD et al (2021) Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety. World J Urol 39(12):4389–4395. https://doi.org/10.1007/s00345-021-03688-4

    Article  PubMed  Google Scholar 

  10. Nickel JC, Aaron L, Barkin J, Elterman D, Nachabé M, Zorn KC (2018) Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update. Can Urol Assoc J 12(10):303–312. https://doi.org/10.5489/cuaj.5616

    Article  PubMed  PubMed Central  Google Scholar 

  11. Foster HE, Barry MJ, Dahm P et al (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol 200(3):612–619. https://doi.org/10.1016/j.juro.2018.05.048

    Article  PubMed  Google Scholar 

  12. Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038

    Article  PubMed  Google Scholar 

  13. Eri LM, Thomassen H, Brennhovd B, Håheim LL (2002) Accuracy and repeatability of prostate volume measurements by transrectal ultrasound. Prostate Cancer Prostatic Dis 5(4):273–278. https://doi.org/10.1038/sj.pcan.4500568

    Article  CAS  PubMed  Google Scholar 

  14. Wang X (2014) Firth logistic regression for rare variant association tests. Front Genet. https://doi.org/10.3389/fgene.2014.00187

    Article  PubMed  PubMed Central  Google Scholar 

  15. Thoulouzan M, Perrouin-Verbe MA, Calves J et al (2017) Outcomes of GreenLight XPS-180W laser photovaporization for BPH larger than 80 mL. Progres en urologie journal de l’Association francaise d’urologie et de la Societe francaise d’urologie 27(8–9):489–496. https://doi.org/10.1016/j.purol.2017.04.001

    Article  CAS  PubMed  Google Scholar 

  16. Altay B, Erkurt B, Kiremit MC, Guzelburc V, Boz MY, Albayrak S (2015) 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 30(1):317–323. https://doi.org/10.1007/s10103-014-1667-4

    Article  PubMed  Google Scholar 

  17. Lanchon C, Fiard G, Long JA et al (2018) Adénomectomie voie haute versus vaporisation prostatique au laser GreenLight 180-W XPS: résultats fonctionnels à long terme pour les adénomes > 80 g. Prog Urol 28(3):180–187. https://doi.org/10.1016/j.purol.2017.12.008

    Article  CAS  PubMed  Google Scholar 

  18. Enikeev D, Misrai V, Rijo E et al (2022) EAU, AUA and NICE guidelines on surgical and minimally invasive treatment of benign prostate hyperplasia: a critical appraisal of the guidelines using the AGREE-II tool. Urol Int 106(1):1–10

    Article  PubMed  Google Scholar 

  19. Management of non-neurogenic male LUTS—DISEASE MANAGEMENT—Uroweb

  20. Zorn K, Zorn KC, Liberman D (2011) How i do it GreenLight 180W XPS photovaporization of the prostate: how i do it, vol 18. http://www.AmericanMedicalSystems.com

  21. Valdivieso R, Meyer CP, Hueber PA et al (2016) Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate? BJU Int 118(4):633–640. https://doi.org/10.1111/bju.13479

    Article  CAS  PubMed  Google Scholar 

  22. Nguyen DD, Misraï V, Bach T et al (2020) Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP. World J Urol 38(12):3227–3233. https://doi.org/10.1007/s00345-020-03137-8

    Article  PubMed  Google Scholar 

  23. Meskawi M, Hueber PA, Valdivieso R et al (2019) Complications and functional outcomes of high-risk patient with cardiovascular disease on antithrombotic medication treated with the 532-nm-laser photo-vaporization Greenlight XPS-180 W for benign prostate hyperplasia. World J Urol 37(8):1671–1678. https://doi.org/10.1007/s00345-018-2560-8

    Article  CAS  PubMed  Google Scholar 

  24. Masucci L, Erman A, Krahn MD, Elterman D (2018) Cost analysis of Greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia. Can Urol Assoc J. https://doi.org/10.5489/cuaj.5267

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nguyen DD, Sadri I, Law K et al (2021) Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) database. World J Urol 39(10):3881–3889. https://doi.org/10.1007/s00345-020-03529-w

    Article  PubMed  Google Scholar 

  26. Lichy I, Law K, Tholomier C et al (2022) Global experience and progress in GreenLight-XPS 180-Watt photoselective vaporization of the prostate. World J Urol. Published online May 2, 2022

  27. Campobasso D, Marchioni M, De Nunzio C et al (2021) Predictors of re-intervention after greenlight laser photoselective vaporization of the prostate: multicenter long/mid-term follow-up experience. MIS. Published online 2021

  28. Law KW, Tholomier C, Nguyen D-D et al (2021) Global Greenlight group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety. World J Urol. Published online April 10, 2021

Download references

Author information

Author notes

  1. Nicholas Corsi and David-Dan Nguyen denotes equal contribution.

Authors and Affiliations

  1. Wayne State University School of Medicine, Detroit, Michigan, USA

    Nicholas Corsi

  2. Division of Urology, University of Toronto, Toronto, ON, Canada

    David-Dan Nguyen & Dean S. Elterman

  3. Division of Urology, McGill University, Montreal, QC, Canada

    Adel Arezki & Iman Sadri

  4. Division of Urology, Université de Montréal, Montreal, QC, Canada

    Kyle Law, Claudia Deyirmendjian, Naeem Bhojani & Kevin C. Zorn

  5. Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada

    David Bouhadana

  6. Department of Oncology and Urology, Centre Hospitalier Universitaire de Tours, Tours, France

    Franck Bruyère

  7. Department of Urology, Hesperia Hospital, Cure Group, Modena, Italy

    Luca Cindolo & Giovanni Ferrari

  8. Department of Urology, ABC Medical Center, Mexico City, Mexico

    Carlos Vasquez-Lastra

  9. Borelli Urologia, Ribeirão Presto, Sao Paulo, Brazil

    Tiago Borelli-Bovo

  10. Centro de Urologia, CDU, Buenos Aires, Argentina

    Edgardo F. Becher

  11. Department of Urology, University of Magdeburg, Madeburg, Germany

    Hannes Cash

  12. Department of Urology, Charité-Universitaetsmedizin Berlin, Berlin, Germany

    Maximillian Reimann

  13. Department of Urology, Hospital Quiron Barcelona, Barcelona, Spain

    Enrique Rijo

  14. Department of Urology, Clinique Pasteur, Toulouse, France

    Vincent Misrai

  15. Department of Urology, Weill Cornell Medical College, New York Presbyterian, New York, USA

    Bilal Chughtai

Authors
  1. Nicholas Corsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David-Dan Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adel Arezki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iman Sadri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyle Law
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David Bouhadana
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Claudia Deyirmendjian
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Naeem Bhojani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dean S. Elterman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Franck Bruyère
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Luca Cindolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Giovanni Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Carlos Vasquez-Lastra
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Tiago Borelli-Bovo
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Edgardo F. Becher
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Hannes Cash
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Maximillian Reimann
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Enrique Rijo
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Vincent Misrai
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Bilal Chughtai
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Kevin C. Zorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NC: Protocol/Project Development, Data Collection or Management, Manuscript Writing and Editing. DDN: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing. AA: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing. IS: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing. KL: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing. DB: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing. CD: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing. NB: Data Collection or Management, Manuscript Writing and Editing. DSE: Data Collection or Management, Manuscript Writing and Editing. FB: Data Collection or Management, Manuscript Writing and Editing. LC: Data Collection or Management, Manuscript Writing and Editing. GF: Data Collection or Management, Manuscript Writing and Editing. CVL: Data Collection or Management, Manuscript Writing and Editing. TBB: Data Collection or Management, Manuscript Writing and Editing. EFB: Data Collection or Management, Manuscript Writing and Editing. HC: Data Collection or Management, Manuscript Writing and Editing. MR: Data Collection or Management, Manuscript Writing and Editing. ER: Data Collection or Management, Manuscript Writing and Editing. VM: Data Collection or Management, Manuscript Writing and Editing. BC: Data Collection or Management, Manuscript Writing and Editing. KCZ: Protocol/Project Development, Data Collection or Management, Data Analysis, Manuscript Writing and Editing.

Corresponding author

Correspondence to Kevin C. Zorn.

Ethics declarations

Conflict of interest

Consultants and proctors for Boston Scientific for greenlight: KZ, DSE, VM, ER, HC, EFB, BC. Investigators and consultants for PROCEPT BioRobotics: VM, TB, NB, KZ. Surgical tutors for Greenlight Xcelerated Performance System (American Medical System-AMS, Minnetonka, MN) and received honoraria for their tutorship: GF, LC. All other authors do not report any relevant conflicts of interest.

Data availability

The datasets generated during and/or analyzed during the current study are readily available from the corresponding author upon request.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corsi, N., Nguyen, DD., Arezki, A. et al. Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database. World J Urol 41, 529–536 (2023). https://doi.org/10.1007/s00345-022-04260-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-022-04260-4

Keywords

search

Navigation